{"rows":[{"id":5982,"title":"From regulation to practice: A scoping review of prescribers’ roles in psilocybin-assisted therapy","authors":"Bélanger Gabriel, Chang Sue-Ling, Masse-Grenier Marianne, Tremblay Marie-Joëlle, Farzin Houman, Garel Nicolas, Dorval Michel","journal":"Drug Science, Policy and Law","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1177/20503245261494890","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.1177/20503245261494890","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Review Article,Safety","study_type":"Review Article","source_name":"Crossref","publication_status":"published","date_added":"2026-10-08 01:20:19","last_checked":"2026-10-08 01:20:19","bibtex":null,"source_record_id":"DOI:10.1177/20503245261494890","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1177/20503245261494890","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1177/20503245261494890","source_url":"https://doi.org/10.1177/20503245261494890","doi":"10.1177/20503245261494890","pmid":"","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5978,"title":"Psychedelics Restructure the Global Workspace of Consciousness","authors":"Yousefi, P.; Shinozuka, K.; Vizeli, P.; Holze, F.; Becker, A. M.; Muller, F.; Liechti, M. E.; Hasler, G.; Rodriguez, C. I.; Luppi, A.; Mediano, P. A. M.","journal":"bioRxiv","publication_date":"2026-10-05","publication_year":2026,"doi":"10.64898/2026.09.28.755172","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.09.28.755172","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Mechanism of Action,Consciousness,Aging,Drug Interactions","study_type":"Other","source_name":"bioRxiv","publication_status":"preprint","date_added":"2026-10-06 01:20:25","last_checked":"2026-10-08 01:22:46","bibtex":null,"source_record_id":"DOI:10.64898/2026.09.28.755172","abstract_available":true,"abstract_source":"bioRxiv","abstract_source_url":"https://doi.org/10.64898/2026.09.28.755172","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"bioRxiv","source_record_id":"DOI:10.64898/2026.09.28.755172","source_url":"https://doi.org/10.64898/2026.09.28.755172","doi":"10.64898/2026.09.28.755172","pmid":"","publication_date":"2026-10-05","importer_version":"2.1.3","text_redistributed":false}},{"id":5974,"title":"Psychedelics and disorders of consciousness: a new frontier in neurotherapeutics.","authors":"Du X, Peng F, Wang X.","journal":"Molecular psychiatry","publication_date":"2026-10-03","publication_year":2026,"doi":"10.1038/s41380-026-03918-4","pubmed_id":"42829371","openalex_id":null,"source_url":"https://doi.org/10.1038/s41380-026-03918-4","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Review Article,Safety","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-05 01:20:04","last_checked":"2026-10-08 01:20:20","bibtex":null,"source_record_id":"PMID:42829371","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1038/s41380-026-03918-4","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42829371","source_url":"https://doi.org/10.1038/s41380-026-03918-4","doi":"10.1038/s41380-026-03918-4","pmid":"42829371","publication_date":"2026-10-03","importer_version":"2.1.3","text_redistributed":false}},{"id":5973,"title":"Serotonergic Toxicity and Hyponatremia Associated with Antidepressant Therapy: The Pivotal Role of SIADH.","authors":"Morena D, Lippi M, Biso L, Lucci F, Turillazzi E, Fineschi V, Scognamiglio P.","journal":"Clinical drug investigation","publication_date":"2026-10-03","publication_year":2026,"doi":"10.1007/s40261-026-01599-z","pubmed_id":"42829418","openalex_id":"https://openalex.org/W7218417106","source_url":"https://doi.org/10.1007/s40261-026-01599-z","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Case Report,Safety,Toxicity,Drug Interactions","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-05 01:20:04","last_checked":"2026-10-08 01:20:23","bibtex":null,"source_record_id":"PMID:42829418","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1007/s40261-026-01599-z","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42829418","source_url":"https://doi.org/10.1007/s40261-026-01599-z","doi":"10.1007/s40261-026-01599-z","pmid":"42829418","publication_date":"2026-10-03","importer_version":"2.1.3","text_redistributed":false}},{"id":5963,"title":"Reduced egocentricity after psilocybin in patients with alcohol use disorder: a pilot randomized controlled trial","authors":"Bukowski, H.; de Timary, P.; Belahda, D.; Igounenc, N.; Mura, T.; Serrand, C.; Luquiens, A.","journal":"medRxiv","publication_date":"2026-09-29","publication_year":2026,"doi":"10.64898/2026.09.26.26364086","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.09.26.26364086","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Mechanism of Action,Clinical Trial,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-09-30 01:20:46","last_checked":"2026-10-06 01:21:04","bibtex":null,"source_record_id":"DOI:10.64898/2026.09.26.26364086","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.09.26.26364086","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.09.26.26364086","source_url":"https://doi.org/10.64898/2026.09.26.26364086","doi":"10.64898/2026.09.26.26364086","pmid":"","publication_date":"2026-09-29","importer_version":"2.1.3","text_redistributed":false}},{"id":5962,"title":"Psilocybin in psychiatry: Current clinical evidence, mechanisms of action and translational perspectives. A literature review based on PubMed-indexed studies","authors":"Nadolski Bartosz, Poćwiardowski Wojciech, Łazarz Sonia, Gromniak-Haniecka Ewa","journal":"Pharmacotherapy in Psychiatry and Neurology","publication_date":"2026-09-29","publication_year":2026,"doi":"10.17219/fpn/237077","pubmed_id":null,"openalex_id":"https://openalex.org/W7214797486","source_url":"https://doi.org/10.17219/fpn/237077","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Review Article","study_type":"Review Article","source_name":"Crossref","publication_status":"published","date_added":"2026-09-30 01:20:19","last_checked":"2026-10-06 01:20:28","bibtex":null,"source_record_id":"DOI:10.17219/fpn/237077","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.17219/fpn/237077","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.17219/fpn/237077","source_url":"https://doi.org/10.17219/fpn/237077","doi":"10.17219/fpn/237077","pmid":"","publication_date":"2026-09-29","importer_version":"2.1.3","text_redistributed":false}},{"id":5959,"title":"Psilocybin for Treatment-Resistant Major Depression: Efficacy, Safety and Therapeutic Mechanisms","authors":"Lea Julia Mertens","journal":null,"publication_date":"2026-09-24","publication_year":2026,"doi":"10.11588/heidok.00039377","pubmed_id":null,"openalex_id":"https://openalex.org/W7214153504","source_url":"https://doi.org/10.11588/heidok.00039377","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Mechanism of Action,Treatment-Resistant Depression,Safety","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-26 01:20:21","last_checked":"2026-10-01 01:20:28","bibtex":null,"source_record_id":"DOI:10.11588/heidok.00039377","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.11588/heidok.00039377","source_url":"https://doi.org/10.11588/heidok.00039377","doi":"10.11588/heidok.00039377","pmid":"","publication_date":"2026-09-24","importer_version":"2.1.3","text_redistributed":false}},{"id":5950,"title":"Exploring the Therapeutic Potential of Psilocybin: A Comprehensive Review of Clinical Trial Evidence and Implications for Rescheduling.","authors":"Abolhasani F, Rezaiezadeh H, Langarizadeh MA, Tavakoli MR, Ilaghi M, Zare P, Ravari FK, Alamdar F, Banazadeh M, Shabani M.","journal":"Mini reviews in medicinal chemistry","publication_date":"2026-09-18","publication_year":2026,"doi":"10.2174/0113895575443239260828094859","pubmed_id":"42770437","openalex_id":"https://openalex.org/W7213987315","source_url":"https://doi.org/10.2174/0113895575443239260828094859","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-23 01:20:07","last_checked":"2026-09-25 01:20:21","bibtex":null,"source_record_id":"PMID:42770437","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.2174/0113895575443239260828094859","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42770437","source_url":"https://doi.org/10.2174/0113895575443239260828094859","doi":"10.2174/0113895575443239260828094859","pmid":"42770437","publication_date":"2026-09-18","importer_version":"2.1.3","text_redistributed":false}},{"id":5948,"title":"EFFICACY AND SAFETY OF PSILOCYBIN IN TREATMENT-RESISTANT DEPRESSION: A REVIEW","authors":"Gawin Mateusz, Koziara Emilia, Gadzina Mateusz, Gawlak Julia, Krzesimir Kuświk Maciej, Tarnawska Zofia, Figiel Karolina, Sontag Wojciech, Zawisza Mateusz, Golec Aleksandra","journal":"International Journal of Innovative Technologies in Social Science","publication_date":"2026-09-21","publication_year":2026,"doi":"10.31435/ijitss.3(51).2026.6573","pubmed_id":null,"openalex_id":"https://openalex.org/W7213945218","source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6573","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-09-22 01:20:19","last_checked":"2026-09-28 01:20:29","bibtex":null,"source_record_id":"DOI:10.31435/ijitss.3(51).2026.6573","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6573","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.31435/ijitss.3(51).2026.6573","source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6573","doi":"10.31435/ijitss.3(51).2026.6573","pmid":"","publication_date":"2026-09-21","importer_version":"2.1.3","text_redistributed":false}},{"id":5945,"title":"Targeting the serotonin 1B receptor for the treatment of depression and anxiety.","authors":"Fleury S, Nautiyal KM.","journal":"Expert opinion on therapeutic targets","publication_date":"2026-09-28","publication_year":2026,"doi":"10.1080/14728222.2026.2738183","pubmed_id":"42766349","openalex_id":"https://openalex.org/W7213928055","source_url":"https://doi.org/10.1080/14728222.2026.2738183","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-22 01:20:05","last_checked":"2026-10-05 01:20:16","bibtex":null,"source_record_id":"PMID:42766349","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1080/14728222.2026.2738183","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42766349","source_url":"https://doi.org/10.1080/14728222.2026.2738183","doi":"10.1080/14728222.2026.2738183","pmid":"42766349","publication_date":"2026-09-28","importer_version":"2.1.3","text_redistributed":false}},{"id":5944,"title":"Psychedelics and suicidality: A double-edged sword - risks, mechanisms, and moving forward.","authors":"Mallevays M, Berkovitch L.","journal":"European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology","publication_date":"2026-09-19","publication_year":2026,"doi":"10.1016/j.euroneuro.2026.113878","pubmed_id":"42762543","openalex_id":"https://openalex.org/W7213658706","source_url":"https://doi.org/10.1016/j.euroneuro.2026.113878","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Safety","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-21 01:20:06","last_checked":"2026-09-26 01:20:21","bibtex":null,"source_record_id":"PMID:42762543","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1016/j.euroneuro.2026.113878","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42762543","source_url":"https://doi.org/10.1016/j.euroneuro.2026.113878","doi":"10.1016/j.euroneuro.2026.113878","pmid":"42762543","publication_date":"2026-09-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5940,"title":"Comparative Policy Analysis of Psychedelic Therapy Regulation in Australia, Brazil, and the USA","authors":"A S Shikha, Jignesh Shah, Darshil B. Shah, Dilip Maheshwari","journal":"Applied Drug Research Clinical Trials and Regulatory Affairs","publication_date":"2026-09-14","publication_year":2026,"doi":"10.2174/0126673371488041260902064242","pubmed_id":null,"openalex_id":"https://openalex.org/W7213466340","source_url":"https://doi.org/10.2174/0126673371488041260902064242","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Review Article,Safety,Toxicity","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-18 01:20:21","last_checked":"2026-09-21 01:20:28","bibtex":null,"source_record_id":"DOI:10.2174/0126673371488041260902064242","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.2174/0126673371488041260902064242","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.2174/0126673371488041260902064242","source_url":"https://doi.org/10.2174/0126673371488041260902064242","doi":"10.2174/0126673371488041260902064242","pmid":"","publication_date":"2026-09-14","importer_version":"2.1.3","text_redistributed":false}},{"id":5939,"title":"High ventilation breathwork as a non-pharmacological model for inducing psychedelic-like states: expert evaluations of therapeutic potential and risk.","authors":"Lueken U, Dziobek I, Havenith MN, Schild M, Daedelow LS.","journal":"Npj mental health research","publication_date":"2026-09-17","publication_year":2026,"doi":"10.1038/s44184-026-00246-x","pubmed_id":"42754646","openalex_id":"https://openalex.org/W7213457361","source_url":"https://doi.org/10.1038/s44184-026-00246-x","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Consciousness,Emotional Processing,Clinical Trial,Safety,Contraindications","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-18 01:20:21","last_checked":"2026-09-24 01:20:20","bibtex":null,"source_record_id":"PMID:42754646","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1038/s44184-026-00246-x","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42754646","source_url":"https://doi.org/10.1038/s44184-026-00246-x","doi":"10.1038/s44184-026-00246-x","pmid":"42754646","publication_date":"2026-09-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5937,"title":"Psilocybin restores social novelty investigation in male SAPAP3 knockout mice and engages prefrontal-hippocampal circuitry.","authors":"Gattuso JJ, Bezcioglu B, Hendey J, Payet JM, Phelan ZJ, Hale MW, Hannan AJ, Renoir T.","journal":"Molecular psychiatry","publication_date":"2026-09-17","publication_year":2026,"doi":"10.1038/s41380-026-03879-8","pubmed_id":"42754621","openalex_id":"https://openalex.org/W7213460784","source_url":"https://doi.org/10.1038/s41380-026-03879-8","substance_tags":"psilocybin","topic_tags":"OCD,Neuroplasticity,Mechanism of Action,Animal Study,Drug Interactions","study_type":"Animal Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-18 01:20:16","last_checked":"2026-09-24 01:20:20","bibtex":null,"source_record_id":"PMID:42754621","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1038/s41380-026-03879-8","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42754621","source_url":"https://doi.org/10.1038/s41380-026-03879-8","doi":"10.1038/s41380-026-03879-8","pmid":"42754621","publication_date":"2026-09-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5934,"title":"Correlation of Ketamine and Classic Psychedelics with Pain-Related Neural Connectivity: A Scoping Review of Clinical Experiments on a Potential Therapeutic Target Concerning Ketamine and Classical Psychedelics Administration for Pain Relief","authors":"Vasileios Chytas, Georgios Tsimploulis, Dimitrios Chytas","journal":"Psychedelic Medicine","publication_date":"2026-09-14","publication_year":2026,"doi":"10.1177/28314425261489067","pubmed_id":null,"openalex_id":"https://openalex.org/W7212693934","source_url":"https://doi.org/10.1177/28314425261489067","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Emotional Processing,Review Article,Toxicity","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-16 01:20:19","last_checked":"2026-09-21 01:20:28","bibtex":null,"source_record_id":"DOI:10.1177/28314425261489067","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1177/28314425261489067","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/28314425261489067","source_url":"https://doi.org/10.1177/28314425261489067","doi":"10.1177/28314425261489067","pmid":"","publication_date":"2026-09-14","importer_version":"2.1.3","text_redistributed":false}},{"id":5928,"title":"Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan.","authors":"Raffa RB.","journal":"Cureus","publication_date":"2026-09-13","publication_year":2026,"doi":"10.7759/cureus.116178","pubmed_id":"42733721","openalex_id":"https://openalex.org/W7212432134","source_url":"https://doi.org/10.7759/cureus.116178","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Mechanism of Action,Review Article,Treatment-Resistant Depression,Drug Interactions,Genomics","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-15 01:20:05","last_checked":"2026-09-20 01:20:21","bibtex":null,"source_record_id":"PMID:42733721","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.7759/cureus.116178","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42733721","source_url":"https://doi.org/10.7759/cureus.116178","doi":"10.7759/cureus.116178","pmid":"42733721","publication_date":"2026-09-13","importer_version":"2.1.3","text_redistributed":false}},{"id":5927,"title":"Modulating the Thermodynamics and Kinetics of Psychedelics at Serotonin Receptors via Terahertz Waves","authors":"Cong Zhang, Mingqi Li, Jing Ma, Yibo Wang, Zihua Song, Xiaohui Wang","journal":"The Journal of Physical Chemistry B","publication_date":"2026-09-12","publication_year":2026,"doi":"10.1021/acs.jpcb.6c03569","pubmed_id":null,"openalex_id":"https://openalex.org/W7140165772","source_url":"https://doi.org/10.1021/acs.jpcb.6c03569","substance_tags":"psilocin","topic_tags":"Pharmacology,Mechanism of Action,Receptor Pharmacology,In Vitro Study,Drug Interactions","study_type":"In Vitro Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-14 01:20:22","last_checked":"2026-09-19 01:20:18","bibtex":null,"source_record_id":"DOI:10.1021/acs.jpcb.6c03569","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1021/acs.jpcb.6c03569","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1021/acs.jpcb.6c03569","source_url":"https://doi.org/10.1021/acs.jpcb.6c03569","doi":"10.1021/acs.jpcb.6c03569","pmid":"","publication_date":"2026-09-12","importer_version":"2.1.3","text_redistributed":false}},{"id":5924,"title":"Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic Review","authors":"Zhang Xizhen, Zhang Xiaowen, Zhang Haiyu, Wei Sheng","journal":"International Journal of Molecular Sciences","publication_date":"2026-09-10","publication_year":2026,"doi":"10.3390/ijms27188052","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.3390/ijms27188052","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression","study_type":"Systematic Review","source_name":"Crossref","publication_status":"published","date_added":"2026-09-13 01:20:11","last_checked":"2026-09-17 01:20:17","bibtex":null,"source_record_id":"DOI:10.3390/ijms27188052","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/ijms27188052","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/ijms27188052","source_url":"https://doi.org/10.3390/ijms27188052","doi":"10.3390/ijms27188052","pmid":"","publication_date":"2026-09-10","importer_version":"2.1.3","text_redistributed":false}},{"id":5923,"title":"Psilocybin and Chronic Neuropathic and Centralized Pain: Converging Mechanisms in Central Sensitization, Neuroplasticity, and Network Organization","authors":"Neves Marina Seixas Studart e, Gusmão Camilla Teixeira Pinheiro, Chiyo Raimundo, Manuel André Aloni João, Ulundo Avelino Hemenegildo, Jacinto Irina, Catumbela Azeres, João Vladimir Carlos Casimiro, Manuel Joel Armando, Pascoal Capela António, Montefusco-Pereira Carlos Victor, Ribeiro Junior Howard Lopes","journal":"Anesthesia Research","publication_date":"2026-09-11","publication_year":2026,"doi":"10.3390/anesthres3030026","pubmed_id":null,"openalex_id":"https://openalex.org/W7212279061","source_url":"https://doi.org/10.3390/anesthres3030026","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Meta-Analysis,Review Article,Case Report,Observational Study,Animal Study,Immune Function","study_type":"Meta-Analysis","source_name":"Crossref","publication_status":"published","date_added":"2026-09-13 01:20:11","last_checked":"2026-09-18 01:20:21","bibtex":null,"source_record_id":"DOI:10.3390/anesthres3030026","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/anesthres3030026","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/anesthres3030026","source_url":"https://doi.org/10.3390/anesthres3030026","doi":"10.3390/anesthres3030026","pmid":"","publication_date":"2026-09-11","importer_version":"2.1.3","text_redistributed":false}},{"id":5918,"title":"Psychedelic 4-AcO-DMT attenuated looming-induced freezing behaviors by activating PrL CaMKIIα neurons in mice.","authors":"Xia K, Wang Y, Liu J, Yao Y, Su R, Yan H.","journal":"Molecular psychiatry","publication_date":"2026-09-09","publication_year":2026,"doi":"10.1038/s41380-026-03894-9","pubmed_id":"42716959","openalex_id":null,"source_url":"https://doi.org/10.1038/s41380-026-03894-9","substance_tags":"psilocybin,psilocin","topic_tags":"Mechanism of Action,Receptor Pharmacology,Emotional Processing,Animal Study","study_type":"Animal Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-11 01:20:04","last_checked":"2026-09-16 01:20:16","bibtex":null,"source_record_id":"PMID:42716959","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1038/s41380-026-03894-9","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42716959","source_url":"https://doi.org/10.1038/s41380-026-03894-9","doi":"10.1038/s41380-026-03894-9","pmid":"42716959","publication_date":"2026-09-09","importer_version":"2.1.3","text_redistributed":false}}],"total":1099,"page":1,"per_page":20,"pages":55,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":"Mechanism of Action","study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}